<DOC>
	<DOCNO>NCT02999009</DOCNO>
	<brief_summary>The purpose study review performance success rate FDA approve cementless hip replacement part call Trident II Tritanium Acetabular Shell . The study specifically look need revise hip replacement 5 year . This compare much happen patient hip replacement similar cementless acetabular shell .</brief_summary>
	<brief_title>Trident II Tritanium Acetabular Shell Outcomes Study</brief_title>
	<detailed_description />
	<criteria>A . Patient sign Institutional Review Board ( IRB ) approve , study specific Informed Patient Consent Form . B . Patient male nonpregnant female age 1880 year age time study device implantation . C. Patient primary diagnosis NonInflammatory Degenerative Joint Disease . D. Patient candidate primary cementless total hip replacement . E. Patient willing able comply postoperative schedule clinical radiographic evaluation . F. Patient Body Mass Index ( BMI ) â‰¥ 40 . G. Patient diagnose Inflammatory Arthritis . H. Patient active suspect latent infection affect hip joint time study device implantation . I . Patient neuromuscular neurosensory deficiency , limit ability evaluate safety efficacy device . J . Patient diagnose systemic disease ( e.g . Lupus Erythematosus ) metabolic disorder ( e.g . Paget 's Disease ) lead progressive bone deterioration . K. Patient immunologically suppress receive steroid excess normal physiological requirement ( e.g . &gt; 30 day ) . L. Patient require revision surgery previously implant total hip replacement hip fusion affect joint . M. Patient previous open surgery affect joint , include arthroscopy . N. Patient require implantation constrain liner . O . Patient known sensitivity device material . P. Patient prisoner .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>